Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sino Biopharmaceutical Limited SBMFF

Set alert

Price alert · SBMFF

All alert types
0.65 USD -0.01 -2.12%

At close · Oct 30

0.6509 Day range 0.6509
0.593 52-week range 0.891
YTD
-25.36%
1 year
-24.49%
Open
0.6509
Prev close
0.665
Mkt cap
11.58B
Vol
1.00K
Avg vol
657
EPS
0.02
P/E
32.55
More statistics
Low
0.6509
High
0.6509
Earnings
Aug 26, 2026

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 26, 2026Earnings: —; estimate 0.01766; surprise —%
  • Sep 1, 2026Dividend: 0.009
  • Sep 3, 2026Dividend: 0.0089
Signals (12)
NameDateAgo
SMA: BearishOct 19, 20262 weeks ago
RSI: OversoldOct 19, 20262 weeks ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
SMA: BullishAug 17, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago
RSI: OverboughtAug 17, 20262 months ago
SMA: BearishAug 5, 20262 months ago
SMA: BearishAug 5, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago
RSI: OversoldAug 5, 20262 months ago

Financial health

Altman Z-Score

2.77 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 2
  • P/B 3

Valuation

P/E 46.9×
FY 2016: 23.8×FY 2017: 89.6×FY 2018: 9.4×FY 2019: 27.3×FY 2020: 42.6×FY 2021: 5.4×FY 2022: 36.7×FY 2023: 29.6×FY 2024: 15.0×FY 2025: 46.9×
FY 2016 5y median 29.6× FY 2025
P/S 3.5×
FY 2016: 2.7×FY 2017: 13.1×FY 2018: 4.1×FY 2019: 5.3×FY 2020: 5.1×FY 2021: 3.0×FY 2022: 2.9×FY 2023: 2.1×FY 2024: 1.8×FY 2025: 3.5×
FY 2016 5y median 2.9× FY 2025
P/B 3.6×
FY 2016: 4.9×FY 2017: 21.1×FY 2018: 2.9×FY 2019: 4.1×FY 2020: 7.2×FY 2021: 2.6×FY 2022: 2.5×FY 2023: 1.8×FY 2024: 1.6×FY 2025: 3.6×
FY 2016 5y median 2.5× FY 2025
P/FCF 14.5×
FY 2016: 18.1×FY 2017: 85.5×FY 2018: 25.1×FY 2019: 35.7×FY 2020: 34.7×FY 2021: 22.8×FY 2022: 16.5×FY 2023: 12.5×FY 2024: 9.1×FY 2025: 14.5×
FY 2016 5y median 14.5× FY 2025
EV/EBITDA 14.5×
FY 2016: 10.7×FY 2017: 41.9×FY 2018: 13.4×FY 2019: 17.1×FY 2020: 21.5×FY 2021: 4.1×FY 2022: 12.0×FY 2023: 8.3×FY 2024: 8.0×FY 2025: 14.5×
FY 2016 5y median 8.3× FY 2025
EV/Sales 3.7×
FY 2016: 2.7×FY 2017: 13.1×FY 2018: 4.0×FY 2019: 5.2×FY 2020: 5.2×FY 2021: 3.0×FY 2022: 3.1×FY 2023: 2.2×FY 2024: 1.8×FY 2025: 3.7×
FY 2016 5y median 3.0× FY 2025
FCF Yield 6.9%
FY 2016: 5.5%FY 2017: 1.2%FY 2018: 4.0%FY 2019: 2.8%FY 2020: 2.9%FY 2021: 4.4%FY 2022: 6.1%FY 2023: 8.0%FY 2024: 10.9%FY 2025: 6.9%
FY 2016 5y median 6.9% FY 2025

Profitability

Gross Margin 82.1%
FY 2016: 79.2%FY 2017: 79.1%FY 2018: 79.9%FY 2019: 79.7%FY 2020: 78.1%FY 2021: 80.1%FY 2022: 82.8%FY 2023: 81.0%FY 2024: 81.5%FY 2025: 82.1%
FY 2016 5y median 81.5% FY 2025
Operating Margin 21.4%
FY 2016: 33.3%FY 2017: 28.2%FY 2018: 23.8%FY 2019: 24.0%FY 2020: 17.7%FY 2021: 18.9%FY 2022: 21.5%FY 2023: 22.1%FY 2024: 21.3%FY 2025: 21.4%
FY 2016 5y median 21.4% FY 2025
Net Margin 7.4%
FY 2016: 12.1%FY 2017: 14.6%FY 2018: 43.3%FY 2019: 19.4%FY 2020: 11.7%FY 2021: 54.4%FY 2022: 9.8%FY 2023: 8.9%FY 2024: 12.1%FY 2025: 7.4%
FY 2016 5y median 9.8% FY 2025
ROE 7.4%
FY 2016: 21.5%FY 2017: 23.6%FY 2018: 31.0%FY 2019: 15.1%FY 2020: 16.5%FY 2021: 48.2%FY 2022: 8.6%FY 2023: 7.7%FY 2024: 11.0%FY 2025: 7.4%
FY 2016 5y median 8.6% FY 2025
ROIC 8.6%
FY 2016: 28.5%FY 2017: 22.7%FY 2018: 10.8%FY 2019: 9.6%FY 2020: 9.6%FY 2021: 8.8%FY 2022: 9.0%FY 2023: 9.4%FY 2024: 10.4%FY 2025: 8.6%
FY 2016 5y median 9.0% FY 2025
ROA 3.0%
FY 2016: 9.3%FY 2017: 10.4%FY 2018: 18.2%FY 2019: 8.1%FY 2020: 5.9%FY 2021: 24.1%FY 2022: 4.0%FY 2023: 3.7%FY 2024: 5.4%FY 2025: 3.0%
FY 2016 5y median 4.0% FY 2025

Growth (YoY)

Revenue 7.4%
FY 2016: 16.3%FY 2017: 4.6%FY 2018: 41.0%FY 2019: 16.0%FY 2020: -2.4%FY 2021: 13.6%FY 2022: -3.1%FY 2023: 0.7%FY 2024: 10.2%FY 2025: 7.4%
FY 2016 FY 2025
Operating Income 8.2%
FY 2016: 76.0%FY 2017: -11.5%FY 2018: 19.1%FY 2019: 16.8%FY 2020: -27.8%FY 2021: 21.2%FY 2022: 10.0%FY 2023: 3.6%FY 2024: 6.0%FY 2025: 8.2%
FY 2016 FY 2025
EPS (diluted) -31.6%
FY 2016: 10.0%FY 2017: 32.4%FY 2018: 276.9%FY 2019: -49.0%FY 2020: -40.0%FY 2021: 386.7%FY 2022: -83.6%FY 2023: -16.9%FY 2024: 90.6%FY 2025: -31.6%
FY 2016 FY 2025
Free Cash Flow 34.2%
FY 2016: 169.9%FY 2017: 5.4%FY 2018: 49.7%FY 2019: 5.6%FY 2020: -3.5%FY 2021: 0.2%FY 2022: 31.3%FY 2023: -4.3%FY 2024: 29.6%FY 2025: 34.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 2.3×FY 2017: 2.4×FY 2018: 1.9×FY 2019: 3.1×FY 2020: 2.1×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.3×FY 2025: 1.4×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.3×
FY 2016: 2.1×FY 2017: 2.3×FY 2018: 1.8×FY 2019: 2.9×FY 2020: 1.9×FY 2021: 1.4×FY 2022: 1.2×FY 2023: 1.0×FY 2024: 1.1×FY 2025: 1.3×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.5×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 0.8×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.5×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -0.1×FY 2017: -0.2×FY 2018: -0.5×FY 2019: -0.3×FY 2020: 0.6×FY 2021: 0.1×FY 2022: 0.8×FY 2023: 0.4×FY 2024: 0.0×FY 2025: 0.5×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 24.5×
FY 2016: 58.8×FY 2017: 53.6×FY 2018: 32.4×FY 2019: 25.3×FY 2020: 13.0×FY 2021: 16.5×FY 2022: 13.0×FY 2023: 11.7×FY 2024: 20.8×FY 2025: 24.5×
FY 2016 5y median 16.5× FY 2025

Dividends

Dividend Yield 1.4%
FY 2016: 1.0%FY 2017: 0.2%FY 2018: 0.8%FY 2019: 0.6%FY 2020: 1.0%FY 2021: 1.2%FY 2022: 1.7%FY 2023: 1.2%FY 2024: 3.6%FY 2025: 1.4%
FY 2016 5y median 1.4% FY 2025
Payout Ratio 65.8%
FY 2016: 23.2%FY 2017: 20.7%FY 2018: 7.9%FY 2019: 17.5%FY 2020: 42.8%FY 2021: 6.4%FY 2022: 49.8%FY 2023: 27.1%FY 2024: 52.8%FY 2025: 65.8%
FY 2016 5y median 49.8% FY 2025

Annual · latest fiscal year ends 2025-12-31